Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
1.300
+0.050 (4.00%)
Mar 9, 2026, 1:13 PM EDT - Market open
Dermata Therapeutics Market Cap
Dermata Therapeutics has a market cap or net worth of $3.10 million as of March 9, 2026. Its market cap has decreased by -52.15% in one year.
Market Cap
3.10M
Enterprise Value
-1.68M
1-Year Change
-52.15%
Ranking
Category
Stock Price
$1.30
Market Cap Chart
Since the IPO on August 13, 2021, Dermata Therapeutics's market cap has decreased from $57.49M to $3.10M, a decrease of -94.60%. That is a compound annual growth rate of -47.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 2.98M | -51.66% |
| Dec 31, 2025 | 6.17M | 124.01% |
| Dec 31, 2024 | 2.76M | 27.62% |
| Dec 29, 2023 | 2.16M | -56.38% |
| Dec 30, 2022 | 4.95M | -65.85% |
| Dec 31, 2021 | 14.49M | -74.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HCW Biologics | 3.57M |
| Acurx Pharmaceuticals | 3.44M |
| SciSparc | 3.15M |
| XORTX Therapeutics | 3.07M |
| Azitra | 2.92M |
| Scinai Immunotherapeutics | 2.71M |
| Enveric Biosciences | 2.70M |
| Propanc Biopharma | 2.68M |